We are live on ! Find out more
William Blair & Company

William Blair & Company Portfolio holdings

AUM $38.4B
1-Year Est. Return 25.71%
This Fund
S&P 500
This Quarter Est. Return
+9.7%
1 Year Est. Return
+25.71%
3 Year Est. Return
+88.7%
5 Year Est. Return
+104.53%
10 Year Est. Return
+665.86%
AUM
$27.3B
AUM Growth
+$2.26B
Cap. Flow
+$202M
Cap. Flow %
0.74%
Top 10 Hldgs %
24.36%
Holding
1,897
New
97
Increased
682
Reduced
737
Closed
88

Top Buys

Rank Stock Value
1
COST icon
Costco
COST
+$28.3M
2
ALL icon
Allstate
ALL
+$25.8M
3
ISRG icon
Intuitive Surgical
ISRG
+$19.6M
4
NEOG icon
Neogen
NEOG
+$17.4M
5
DV icon
DoubleVerify
DV
+$17.3M

Top Sells

Rank Stock Value
1
NBIX icon
Neurocrine Biosciences
NBIX
+$29.1M
2
PLNT icon
Planet Fitness
PLNT
+$20.4M
3
ABNB icon
Airbnb
ABNB
+$17.1M
4
IBM icon
IBM
IBM
+$14.8M
5
XMTR icon
Xometry
XMTR
+$10.8M

Sector Composition

Rank Sector Weight
1 Technology 25.59%
2 Healthcare 18.44%
3 Industrials 11.64%
4 Financials 11.51%
5 Consumer Discretionary 8.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FHN icon
1401
First Horizon
FHN
$12.3B
$195K ﹤0.01%
17,313
-1,342
-7% -$18K
CXM icon
1402
Sprinklr
CXM
$1.58B
$195K ﹤0.01%
+14,075
New +$182K
BV icon
1403
BrightView Holdings
BV
$1.08B
$194K ﹤0.01%
27,050
-500
-2% -$3.16K
KELYA icon
1404
Kelly Services Class A
KELYA
$536M
$194K ﹤0.01%
11,000
RGF
1405
DELISTED
The Real Good Food Company, Inc. Class A Common Stock
RGF
$193K ﹤0.01%
4,636
+161
+4% +$7.12K
VONV icon
1406
Vanguard Russell 1000 Value ETF
VONV
$22B
$193K ﹤0.01%
2,782
-600
-18% -$40.3K
SURG icon
1407
SurgePays
SURG
$6.86M
$192K ﹤0.01%
26,327
IPAY icon
1408
Amplify Mobile Payments ETF
IPAY
$181M
$192K ﹤0.01%
4,493
-10
-0.2% -$416
CRDF icon
1409
Cardiff Oncology
CRDF
$77.1M
$192K ﹤0.01%
130,500
CNK icon
1410
Cinemark Holdings
CNK
$4.32B
$190K ﹤0.01%
11,527
-187
-2% -$3.11K
BASE
1411
DELISTED
Couchbase
BASE
$188K ﹤0.01%
+11,900
New +$195K
EMC icon
1412
Global X Emerging Markets Great Consumer ETF
EMC
$57.1M
$188K ﹤0.01%
+7,527
New +$186K
BBD icon
1413
Banco Bradesco
BBD
$34.9B
$187K ﹤0.01%
54,068
-121
-0.2% -$374
TAK icon
1414
Takeda Pharmaceutical
TAK
$55.6B
$183K ﹤0.01%
11,669
-55
-0.5% -$901
XMMO icon
1415
Invesco S&P MidCap Momentum ETF
XMMO
$7.63B
$183K ﹤0.01%
2,300
JOBY icon
1416
Joby Aviation
JOBY
$7.87B
$183K ﹤0.01%
17,820
-50
-0.3% -$271
NFRA icon
1417
FlexShares STOXX Global Broad Infrastructure Index Fund
NFRA
$3.03B
$183K ﹤0.01%
3,489
-1,309
-27% -$68.5K
KIE icon
1418
State Street SPDR S&P Insurance ETF
KIE
$676M
$182K ﹤0.01%
4,450
-25
-0.6% -$996
SCHH icon
1419
Schwab US REIT ETF
SCHH
$11.3B
$179K ﹤0.01%
9,189
+317
+4% +$6.08K
VONG icon
1420
Vanguard Russell 1000 Growth ETF
VONG
$45.7B
$179K ﹤0.01%
2,536
-2,148
-46% -$141K
ICVT icon
1421
iShares Convertible Bond ETF
ICVT
$7.62B
$179K ﹤0.01%
2,341
FNDX icon
1422
Schwab Fundamental US Large Company Index ETF
FNDX
$27.4B
$177K ﹤0.01%
9,246
-7,179
-44% -$133K
TWO
1423
Two Harbors Investment
TWO
$1.27B
$176K ﹤0.01%
12,690
-1,683
-12% -$22.2K
PCT icon
1424
PureCycle Technologies
PCT
$1.44B
$176K ﹤0.01%
+16,471
New +$119K
HLN icon
1425
Haleon
HLN
$43.2B
$176K ﹤0.01%
21,008
-722
-3% -$6.16K

Similar funds

William Blair & Company's Q2 2023 Portfolio in Review

As of Q2 2023, William Blair & Company held 1,897 positions worth $27.3B, up 9% from $25B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

William Blair & Company's Q2 2023 filing shows 97 new, 682 increased, 737 reduced and 88 closed positions. Its largest new stake was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M. The largest sale was Neurocrine Biosciences, an estimated $29.1M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 25% a quarter earlier, followed by Healthcare and Industrials.

  • William Blair & Company's largest Q2 2023 buy was Innovator US Equity Power Buffer ETF April: 112,249 shares worth $3.47M.
  • William Blair & Company added most to Costco in Q2 2023, an estimated $28.3M increase.
  • William Blair & Company's biggest Q2 2023 reduction was Neurocrine Biosciences, cutting an estimated $29.1M.
  • William Blair & Company fully exited ABB Ltd in Q2 2023, selling an estimated $7.21M.
  • William Blair & Company's ten largest holdings make up 24% of its $27.3B portfolio in Q2 2023.
  • William Blair & Company opened 97 new positions and closed 88 in Q2 2023.
  • William Blair & Company's portfolio value rose 9% quarter-over-quarter to $27.3B.

Based on William Blair & Company's 13F filing for Q2 2023, filed 11 Aug 2023.